Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim

J Cardiovasc Pharmacol. 1993 Feb;21(2):279-88. doi: 10.1097/00005344-199302000-00014.

Abstract

The negative inotropic responses of guinea pig isolated left atria to the P1-receptor agonists adenosine and L-N6-phenylisopropyladenosine (L-PIA), the muscarinic receptor agonist carbachol, and the potassium channel activator cromakalim were examined. The potassium channel blocker 4-aminopyridine (4-AP, 10 mM) decreased the concentration-response curve for L-N-6-phenylisopropyladenosine (L-PIA) so that the maximum reduction in atrial tension was significantly reduced from 77.8 to 61.9%. The concentration-response curve for the negative inotropic response to carbachol was displaced to the right by a substantially greater amount (521-fold), partly due to the muscarinic receptor blocking activity of 4-AP. The response to a single submaximum dose of L-PIA (520 nM) was slow in onset and monophasic, whereas adenosine induced a rapid reduction in tension followed by a gradual return toward the resting level. In the presence of 4-AP (10 mM), the peak response to L-PIA was significantly reduced from a 59.7 to 31.0% inhibition of tension. In addition, the rate of development of the response was significantly slowed. The peak inhibition of tension by adenosine (112 microM) (60.0%) was also significantly reduced to 37.4% in the presence of 4-AP (10 mM). Furthermore, there was no rapid decrease in tension but a gradual decrease to a peak effect which was no different from that in the absence of 4-AP. These results suggest that the P1-receptor agonists exert negative inotropy through a K+ channel-dependent component which is blocked by 4-AP and a slower-onset K+ channel-independent component. The potassium channel blocker, bromobenzoylmethyladamantylamine (BMA 100 microM) also shifted (11-fold) the concentration-response curve for the negative inotropic response to adenosine, and to a lesser extent that to cromakalim (2.1-fold) and carbachol. Glibenclamide (0.3, 3, and 30 microM), a selective antagonist of ATP-regulated potassium channels, was a potent antagonist of the negative inotropic responses to cromakalim. However, 30 microM failed to antagonize the responses to L-PIA, adenosine, or carbachol, indicating that they do not mediate their responses through ATP-regulated potassium channels. 4-AP (10 mM) caused a slight shift (2.3-fold) of the concentration-response curve for cromakalim, indicating weak activity against ATP-regulated potassium channels in the left atrium. This study showed that P1-receptor agonists exert negative inotropic responses in guinea pig left atria only in part through activation of potassium channels. These channels differ from the ATP-regulated potassium channels activated by cromakalim.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Adenosine / pharmacology
  • Animals
  • Benzopyrans / pharmacology*
  • Carbachol / pharmacology
  • Cromakalim
  • Depression, Chemical
  • Glyburide / pharmacology
  • Guinea Pigs
  • Heart Atria / drug effects*
  • Hydrochloric Acid / pharmacology
  • In Vitro Techniques
  • Male
  • Myocardial Contraction / drug effects*
  • Parasympatholytics / pharmacology*
  • Phenylisopropyladenosine / pharmacology
  • Potassium Channels / drug effects*
  • Pyrroles / pharmacology*
  • Receptors, Muscarinic / drug effects*
  • Receptors, Purinergic / drug effects*
  • Rubidium Radioisotopes

Substances

  • Benzopyrans
  • Parasympatholytics
  • Potassium Channels
  • Pyrroles
  • Receptors, Muscarinic
  • Receptors, Purinergic
  • Rubidium Radioisotopes
  • Cromakalim
  • Phenylisopropyladenosine
  • Carbachol
  • 4-Aminopyridine
  • Adenosine
  • Hydrochloric Acid
  • Glyburide